BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25172603)

  • 21. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
    Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.
    Nag S; Cano ER; Demanes DJ; Puthawala AA; Vikram B;
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1190-8. PubMed ID: 11483328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
    Strnad V; Lotter M; Kreppner S; Fietkau R
    Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.
    Yamazaki H; Masui K; Suzuki G; Yoshida K; Nakamura S; Isohashi F; Kotsuma T; Takaoka Y; Tanaka E; Akiyama H; Ishibashi N
    Brachytherapy; 2022; 21(3):341-346. PubMed ID: 35307301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
    Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
    Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brachytherapy for radiotherapy-resistant head and neck cancer: A review of a single center experience.
    Hazkani I; Rabinovics N; Limon D; Silvern D; Koren S; Hadar T; Bachar G; Shpitzer T; Popovtzer A
    Laryngoscope; 2016 Oct; 126(10):2246-51. PubMed ID: 26928864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
    Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
    Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.
    Ward MC; Lee NY; Caudell JJ; Zajichek A; Awan MJ; Koyfman SA; Dunlap NE; Zakem SJ; Hassanzadeh C; Marcrom S; Boggs DH; Isrow D; Vargo JA; Heron DE; Siddiqui F; Bonner JA; Beitler JJ; Yao M; Trotti AM; Riaz N;
    Oral Oncol; 2019 Mar; 90():80-86. PubMed ID: 30846182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficiency and adverse events of radiotherapy with cetuximab for Japanese head and neck cancer patients.
    Hirasawa K; Okamoto I; Motohashi R; Sato H; Takase S; Agata A; Takeda A; Tsukahara K
    Auris Nasus Larynx; 2017 Dec; 44(6):724-728. PubMed ID: 28237712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.
    Duprez F; Berwouts D; Madani I; Bonte K; Boterberg T; De Gersem W; Deron P; Huvenne W; De Neve W
    Radiother Oncol; 2014 Jun; 111(3):388-92. PubMed ID: 24998706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial.
    Wu KL; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Zhao S
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1345-50. PubMed ID: 14630272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.
    Teckie S; Scala LM; Ho F; Wolden S; Chiu J; Cohen GN; Wong R; Ganly I; Zelefsky MJ; Lee NY
    Brachytherapy; 2013; 12(3):228-34. PubMed ID: 23466361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.
    Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK
    Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
    Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
    Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases.
    Teudt IU; Kovàcs G; Ritter M; Melchert C; Soror T; Wollenberg B; Meyer JE
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2707-15. PubMed ID: 26498949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.
    Al-Wassia R; Vakilian S; Holly C; Sultanem K; Shenouda G
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):31. PubMed ID: 26330008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Okazawa M; Sasano T; Maruoka S; Anzai M; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2014 Jan; 24(1):141-8. PubMed ID: 24362719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer.
    Zwicker F; Roeder F; Hauswald H; Thieke C; Timke C; Schlegel W; Debus J; Münter MW; Huber PE
    Head Neck; 2011 Dec; 33(12):1695-702. PubMed ID: 21284054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.